A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

Researchers have discovered that the SARS-CoV-2 spike protein persists in the brain and skull bone marrow for years after ...

Another year has gone by since the 2020 pandemic and COVID-19 remains at large, so experts weigh in on what will change in 2025.

The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...

During the current "silent" COVID-19 surge, you are at greater risk for getting infected with the SARS-CoV-2. Here's what to ...

While there is a whole host of viruses going around, there are thankfully no new viruses to fret about—the ones we have are ...

The following is a summary of “Four COVID-19 screening strategies for early case identification within the homeless shelter ...

A new report published in the journal Communications Medicine suggests Pfizer’s (PFE) Paxlovid may help some long Covid patients, but which ...

It can take several weeks to bounce back after a bout of COVID-19, but some people develop more persistent problems. The ...

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

Coronavirus Disease 2019 (SARS-CoV-2) vaccine is under clinical development by Shionogi and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

In the first two years of the covid-19 pandemic, numerous New Scientist covers were dedicated to the global emergency caused ...